Quidel Corporation (QDEL) stock is soaring 7.18% in pre-market trading on Monday, as investors react positively to a new trade agreement between the United States and China. The deal, which aims to slash tariffs, has sparked a broad rally across the life sciences sector.
The US-China trade agreement is expected to significantly benefit companies in the life sciences industry, potentially reducing costs and improving access to the Chinese market. Quidel, a prominent player in the diagnostic healthcare products market, is among several companies in the sector seeing substantial gains.
Other major players in the life sciences industry are also experiencing notable increases in their stock prices. Bio-Techne is up 6.1%, Bio-Rad Laboratories has risen 5.9%, and Thermo Fisher Scientific has gained 4.7%. This sector-wide rally underscores the potential impact of the trade deal on companies involved in medical research, diagnostics, and healthcare technology.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。